109 related articles for article (PubMed ID: 478772)
1. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil.
Abrams DN; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):97-101. PubMed ID: 478772
[No Abstract] [Full Text] [Related]
2. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--II. 6-[3H]-5-fluoro-2'-deoxyuridine.
Abrams DN; Knaus EE; Lentle BC; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):103-7. PubMed ID: 157998
[No Abstract] [Full Text] [Related]
3. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--III. 2'-[82Br]-bromo-2'-deoxyuridine.
Lee YW; Knaus EE; Wiebe LI
Int J Nucl Med Biol; 1979; 6(2):109-112. PubMed ID: 113355
[No Abstract] [Full Text] [Related]
4. Distribution of 18F-5-fluorouracil in tumor-bearing mice and rats.
Shani J; Wolf W; Schlesinger T; Atkins HL; Bradley-Moore PR; Casella V; Fowler JS; Greenberg D; Ido T; Lambrecht RM; MacGregor R; Mantescu C; Neirinckx R; Som P; Wolf AP; Wodinsky I; Meaney K
Int J Nucl Med Biol; 1978 Mar; 5(1):19-28. PubMed ID: 207653
[No Abstract] [Full Text] [Related]
5. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--VIII. Synthesis and tissue distribution of N-[2-(hydroxyethoxy) methyl]-5-[3H]methyluracil.
Lee YW; Iwashina T; Gati WP; Knaus EE; Wiebe LI
Int J Appl Radiat Isot; 1985 May; 36(5):395-8. PubMed ID: 4018900
[TBL] [Abstract][Full Text] [Related]
6. The disposition of the antitumor agent, sangivamycin, in mice.
Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899
[No Abstract] [Full Text] [Related]
7. [Effect of ascorbic acid on incorporation of 5-fluorouracil-6-3H into acid-soluble fraction and into RNA of sensitive and resistant to 5-fluorouracil cells of Ehrlich ascites carcinoma].
Shlemkevich MP
Biull Eksp Biol Med; 1982 Feb; 93(2):56-7. PubMed ID: 7066528
[No Abstract] [Full Text] [Related]
8. [Estimation of tumor sensitivity in vitro. II. Studies with the solid Ehrlich carcinoma of the mouse and the GW 77, a heterotransplanted human carcinoma].
Seidel HJ
Z Krebsforsch; 1970; 74(2):131-40. PubMed ID: 4103128
[No Abstract] [Full Text] [Related]
9. [On uptake of 5-FU, 6-MP and methotrexate by ehrlich ascites tumor cells in vitro].
Oriuchi T
Sapporo Igaku Zasshi; 1970 Jun; 37(6):255-67. PubMed ID: 5534721
[No Abstract] [Full Text] [Related]
10. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models--V. 6-[36Cl]chlorouracil, 6-[82Br]bromouracil and 6-[123I]iodouracil.
Lee YW; Abrams DN; Wiebe LI; Knaus EE
Int J Nucl Med Biol; 1984; 11(3-4):262-6. PubMed ID: 6549392
[No Abstract] [Full Text] [Related]
11. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies.
Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452
[TBL] [Abstract][Full Text] [Related]
12. [Utilization of pyrimidine precursors in the tumor and liver of mice with Ehrlich ascites carcinoma].
Fedorov NA; Matveenko VN; Tikhonova EF
Biull Eksp Biol Med; 1970 Dec; 70(12):66-9. PubMed ID: 5503816
[No Abstract] [Full Text] [Related]
13. Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro.
Gotto AM; Belkhode ML; Touster O
Cancer Res; 1969 Apr; 29(4):807-11. PubMed ID: 5775710
[No Abstract] [Full Text] [Related]
14. PYRIMIDINE METABOLISM IN TISSUE CULTURE CELLS DERIVED FROM RAT HEPATOMAS. 3. RELATIONSHIP OF THYMIDINE TO THE METABOLISM OF OTHER PYRIMIDINE NUCLEOSIDES IN SUSPENSION CULTURES DERIVED FROM THE NOVIKOFF HEPATOMA.
GENTRY GA; MORSE PA; POTTER VR
Cancer Res; 1965 May; 25():517-25. PubMed ID: 14302036
[No Abstract] [Full Text] [Related]
15. Tumor uptake of radiolabelled pyrimidine bases and pyrimidine nucleosides in animal models: VI. 1-(3'-[36Cl]-chloro-, 1-(3'-[82Br]-bromo- and 1-(3'-[123I]-Iodo-3'-deoxy-beta-D-arabinofuranosyl)uracil.
Lee YW; Mercer JR; Wiebe LI; Knaus EE
Int J Appl Radiat Isot; 1984 Nov; 35(11):1057-61. PubMed ID: 6526522
[TBL] [Abstract][Full Text] [Related]
16. UTILIZATION OF DNA AND RNA PRECURSORS AS INDICATORS OF DRUG EFFECT ON CANCER CELLS. ANL-6723.
STROUD AN; MCDONALD GO; SVOBODA BR; BRUES AM
ANL Rep; 1963 May; ():237-42. PubMed ID: 14131021
[No Abstract] [Full Text] [Related]
17. Effect of N1-(2'-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on nucleic acid and protein biosyntheses in Ehrlich ascites cells.
Fujimoto S; Akao T; Itoh B; Koshizuka I; Koyano K
Cancer Res; 1976 Jan; 36(1):33-6. PubMed ID: 1248008
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
[TBL] [Abstract][Full Text] [Related]
19. Arabinosyladenine and arabinosylhypoxanthine metabolism in murine tumor cells.
LePage GA
Can J Biochem; 1970 Jan; 48(1):75-8. PubMed ID: 5512545
[No Abstract] [Full Text] [Related]
20. [Biochemical differences in the tumor cells of 5-fluorouracil-sensitive and -resistant strains of Ehrlich ascitic carcinoma].
Shlemkevich MP
Biull Eksp Biol Med; 1983 Feb; 95(2):72-4. PubMed ID: 6824782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
